Literature DB >> 23943015

Late presentation and loss to follow-up of immigrants newly diagnosed with HIV in the HAART era.

A Saracino1, A Tartaglia, G Trillo, C Muschitiello, C Bellacosa, G Brindicci, L Monno, G Angarano.   

Abstract

To compare clinical characteristics and therapeutic management of newly HIV-diagnosed immigrants to natives. Patients with a first HIV diagnosis from 1996 to 2010 were included. Of 716 new diagnoses, 85 (12 %) were immigrants. Migrants were younger, more frequently females and sexually infected, less likely to voluntarily request testing, and less HCV-coinfected. Late presenters (CD4 <350 or AIDS) were 76 % among migrants versus 56 % in natives (p = 0.006) with an increasing trend over time. HAART was initiated in 76.5 % of natives and 72.4 % of immigrants; the number/type of adverse events and treatment discontinuation were similar. Immigrants received more NNRTIs-based regimens. A similar proportion of patients reached virological suppression at month 1-3-6 after HAART initiation, but 43 % of immigrants versus 27 % of natives resulted lost to follow-up (p < 0.001). Diagnosis of HIV was often delayed among migrants, who also presented a higher rate of lost to follow-up.

Entities:  

Mesh:

Year:  2014        PMID: 23943015     DOI: 10.1007/s10903-013-9863-z

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  9 in total

1.  Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.

Authors:  Cornelia Staehelin; Olivia Keiser; Alexandra Calmy; Rainer Weber; Luigia Elzi; Matthias Cavassini; Patrick Schmid; Enos Bernasconi; Hansjakob Furrer
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

2.  Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study.

Authors:  José A Pérez Molina; Marta Mora Rillo; Ignacio Suárez-Lozano; Jose L Casado Osorio; Ramón Teira Cobo; Pablo Rivas González; Enric Pedrol Clotet; Asunción Hernando Jerez; Pere Domingo Pedrol; Ana Royuela; Elena Barquilla Díaz; Herminia Esteban; Juan González-García
Journal:  Curr HIV Res       Date:  2010-10       Impact factor: 1.581

Review 3.  Barriers to HIV testing for migrant black Africans in Western Europe.

Authors:  I Fakoya; R Reynolds; G Caswell; I Shiripinda
Journal:  HIV Med       Date:  2008-07       Impact factor: 3.180

4.  Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.

Authors:  C Thierfelder; R Weber; L Elzi; H Furrer; M Cavassini; A Calmy; E Bernasconi; C Gutmann; B Ledergerber
Journal:  HIV Med       Date:  2011-11-22       Impact factor: 3.180

5.  Access to HAART in HIV-infected immigrants: a retrospective multicenter Italian study.

Authors:  A Saracino; I El-Hamad; R Prato; D C Cibelli; A Tartaglia; E Palumbo; M C Pezzoli; G Angarano; G Scotto
Journal:  AIDS Patient Care STDS       Date:  2005-09       Impact factor: 5.078

6.  The economic burden of late entry into medical care for patients with HIV infection.

Authors:  John A Fleishman; Baligh R Yehia; Richard D Moore; Kelly A Gebo
Journal:  Med Care       Date:  2010-12       Impact factor: 2.983

7.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

8.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

Authors:  Gonzalo Yebra; Miguel de Mulder; María Jesús Pérez-Elías; José Antonio Pérez-Molina; Juan Carlos Galán; Jara Llenas-García; Santiago Moreno; África Holguín
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

  9 in total
  6 in total

1.  Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence.

Authors:  Barbara S Taylor; Emily Reyes; Elizabeth A Levine; Shah Z Khan; L Sergio Garduño; Yeycy Donastorg; Scott M Hammer; Karen Brudney; Jennifer S Hirsch
Journal:  AIDS Patient Care STDS       Date:  2014-05-19       Impact factor: 5.078

2.  Co-morbid Non-communicable Diseases and Associated Health Service Use in African and Caribbean Immigrants with HIV.

Authors:  Khatundi-Irene Masindi; Nathaniel Jembere; Claire E Kendall; Ann N Burchell; Ahmed M Bayoumi; Mona Loutfy; Janet Raboud; Sean B Rourke; Henry Luyombya; Tony Antoniou
Journal:  J Immigr Minor Health       Date:  2018-06

3.  Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort.

Authors:  Donna M Tilley; Elizabeth Griggs; Jennifer Hoy; Stephen T Wright; Ian Woolley; Michael Burke; Catherine C O'Connor
Journal:  AIDS Care       Date:  2015

4.  Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study.

Authors:  Viviane Dias Lima; Nicola Goldberg; Lillian Lourenço; William Chau; Robert S Hogg; Silvia Guillemi; Rolando Barrios; Julio S G Montaner
Journal:  BMC Health Serv Res       Date:  2015-09-14       Impact factor: 2.655

Review 5.  Prevalence and Clinical Characteristics of Mycobacterial Diseases in the Barletta-Andria-Trani Province, Italy (2005-2013).

Authors:  Gaetano Brindicci; Carmen Rita Santoro; Giovanna Trillo; Anna Volpe; Daniela Loconsole; Laura Monno; Tommaso Fontana
Journal:  Biomed Res Int       Date:  2016-01-17       Impact factor: 3.411

6.  "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014.

Authors:  Houlin Tang; Yurong Mao; Weiming Tang; Jing Han; Juan Xu; Jian Li
Journal:  BMC Infect Dis       Date:  2018-06-13       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.